BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9125526)

  • 21. Raman difference studies of GDP and GTP binding to c-Harvey ras.
    Wang JH; Xiao DG; Deng H; Webb MR; Callender R
    Biochemistry; 1998 Aug; 37(31):11106-16. PubMed ID: 9693007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The frozen solution structure of p21 ras determined by ESEEM spectroscopy reveals weak coordination of Thr35 to the active site metal ion.
    Farrar CT; Halkides CJ; Singel DJ
    Structure; 1997 Aug; 5(8):1055-66. PubMed ID: 9309221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of cryoprotection on the structure and activity of p21 ras: implications for electron spin-echo envelope modulation spectroscopy.
    Halkides CJ; Farrar CT; Singel DJ
    J Magn Reson; 1998 Sep; 134(1):142-53. PubMed ID: 9740740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformation of a Cdc42/Rac interactive binding peptide in complex with Cdc42 and analysis of the binding interface.
    Stevens WK; Vranken W; Goudreau N; Xiang H; Xu P; Ni F
    Biochemistry; 1999 May; 38(19):5968-75. PubMed ID: 10320322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calculation of pathways for the conformational transition between the GTP- and GDP-bound states of the Ha-ras-p21 protein: calculations with explicit solvent simulations and comparison with calculations in vacuum.
    Diaz JF; Wroblowski B; Schlitter J; Engelborghs Y
    Proteins; 1997 Jul; 28(3):434-51. PubMed ID: 9223188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible binding proteins of ras p21 in human erythrocyte membrane.
    Tanimoto T
    Kobe J Med Sci; 1990 Aug; 36(3-4):71-86. PubMed ID: 2096262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the active site of p21 ras by electron spin-echo envelope modulation spectroscopy with selective labeling: comparisons between GDP and GTP forms.
    Halkides CJ; Farrar CT; Larsen RG; Redfield AG; Singel DJ
    Biochemistry; 1994 Apr; 33(13):4019-35. PubMed ID: 8142406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S111N mutation in the helical domain of human Gs(alpha) reduces its GDP/GTP exchange rate.
    Brito M; Guzmán L; Romo X; Soto X; Hinrichs MV; Olate J
    J Cell Biochem; 2002; 85(3):615-20. PubMed ID: 11968001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of guanosine triphosphate hydrolysis by Ras and Ras-GAP proteins as rationalized by ab initio QM/MM simulations.
    Grigorenko BL; Nemukhin AV; Shadrina MS; Topol IA; Burt SK
    Proteins; 2007 Feb; 66(2):456-66. PubMed ID: 17094109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand binding is the principal determinant of stability for the p21(H)-ras protein.
    Zhang J; Matthews CR
    Biochemistry; 1998 Oct; 37(42):14881-90. PubMed ID: 9778364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change in protein flexibility upon complex formation: analysis of Ras-Raf using molecular dynamics and a molecular framework approach.
    Gohlke H; Kuhn LA; Case DA
    Proteins; 2004 Aug; 56(2):322-37. PubMed ID: 15211515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pH-dependent perturbation of Ras-guanine nucleotide interactions and Ras guanine nucleotide exchange.
    Heo J; Gao G; Campbell SL
    Biochemistry; 2004 Aug; 43(31):10102-11. PubMed ID: 15287738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucosylation of Ras by Clostridium sordellii lethal toxin: consequences for effector loop conformations observed by NMR spectroscopy.
    Geyer M; Wilde C; Selzer J; Aktories K; Kalbitzer HR
    Biochemistry; 2003 Oct; 42(41):11951-9. PubMed ID: 14556626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of increased length and intact capping sequences to the conformational preference for helix in a 31-residue peptide from the C terminus of myohemerythrin.
    Reymond MT; Huo S; Duggan B; Wright PE; Dyson HJ
    Biochemistry; 1997 Apr; 36(17):5234-44. PubMed ID: 9136885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic properties of the Ras switch I region and its importance for binding to effectors.
    Spoerner M; Herrmann C; Vetter IR; Kalbitzer HR; Wittinghofer A
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4944-9. PubMed ID: 11320243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of ligand binding in the kinetic folding mechanism of human p21(H-ras) protein.
    Zhang J; Matthews CR
    Biochemistry; 1998 Oct; 37(42):14891-9. PubMed ID: 9778365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of a novel GDP exchange inhibitor with the Ras protein.
    Ganguly AK; Wang YS; Pramanik BN; Doll RJ; Snow ME; Taveras AG; Remiszewski S; Cesarz D; del Rosario J; Vibulbhan B; Brown JE; Kirschmeier P; Huang EC; Heimark L; Tsarbopoulos A; Girijavallabhan VM; Aust RM; Brown EL; DeLisle DM; Fuhrman SA; Hendrickson TF; Kissinger CR; Love RA; Sisson WA; Webber SE
    Biochemistry; 1998 Nov; 37(45):15631-7. PubMed ID: 9843367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic polymorphism of Ras observed by single molecule FRET is the basis for molecular recognition.
    Arai Y; Iwane AH; Wazawa T; Yokota H; Ishii Y; Kataoka T; Yanagida T
    Biochem Biophys Res Commun; 2006 May; 343(3):809-15. PubMed ID: 16564025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and dynamics of the full-length lipid-modified H-Ras protein in a 1,2-dimyristoylglycero-3-phosphocholine bilayer.
    Gorfe AA; Hanzal-Bayer M; Abankwa D; Hancock JF; McCammon JA
    J Med Chem; 2007 Feb; 50(4):674-84. PubMed ID: 17263520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structures of N-terminally processed KRAS provide insight into the role of N-acetylation.
    Dharmaiah S; Tran TH; Messing S; Agamasu C; Gillette WK; Yan W; Waybright T; Alexander P; Esposito D; Nissley DV; McCormick F; Stephen AG; Simanshu DK
    Sci Rep; 2019 Jul; 9(1):10512. PubMed ID: 31324887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.